A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

Semaglutide (Ozempic) improves blood sugar control and weight loss in people with type 1 diabetes and obesity using insulin pumps, new study shows.

Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors could lessen the impacts of stroke and related brain ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

An early study hints at an intriguing possibility: The weight-loss drug Ozempic might allow people newly diagnosed with Type 1 diabetes to drop their daily insulin shots.

For people who are obese and have type 2 diabetes, using Ozempic and other GLP-1 agonist drugs cuts the all-cause mortality rate by 30%, according to a new Use of GLP-1 agonists also cut the risk that ...

Patients with type 1 diabetes could possibly cease daily insulin injections thanks to the “miracle” weight loss drug Ozempic originally developed to combat type 2 diabetes, Metro News reported ...

People often ask whether Ozempic helps them lose weight. Clinical trials have shown reductions in body weight among adults ...

New research finds that men taking a GLP-1 for their obesity or type 2 diabetes often experience a rise in testosterone levels.

Ozempic-style drugs treat type 1 diabetes, not only type 2, study finds. Jennifer Zieba. Wed, July 2, 2025 at 9:00 PM UTC. When you buy through links on our articles, Future and its syndication ...

An early study hints at an intriguing possibility: The weight-loss drug Ozempic might allow people newly diagnosed with Type 1 diabetes to drop their daily insulin shots.